Compare TNYA & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNYA | MNTK |
|---|---|---|
| Founded | 2016 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.4M | 202.0M |
| IPO Year | 2021 | 2020 |
| Metric | TNYA | MNTK |
|---|---|---|
| Price | $0.73 | $1.57 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $5.33 | $1.80 |
| AVG Volume (30 Days) | ★ 3.1M | 152.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.96 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $176,382,000.00 |
| Revenue This Year | N/A | $18.55 |
| Revenue Next Year | N/A | $12.68 |
| P/E Ratio | ★ N/A | $146.00 |
| Revenue Growth | N/A | ★ 0.37 |
| 52 Week Low | $0.53 | $1.07 |
| 52 Week High | $2.35 | $2.78 |
| Indicator | TNYA | MNTK |
|---|---|---|
| Relative Strength Index (RSI) | 47.31 | 48.54 |
| Support Level | $0.65 | $1.33 |
| Resistance Level | $0.82 | $1.72 |
| Average True Range (ATR) | 0.05 | 0.09 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 38.61 | 22.00 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.